Brief: CASI Pharmaceuticals reports Q2 results
12/08/2022 12:08
Aug 12 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2022
FINANCIAL
RESULTS
* Q2 REVENUE $8.6 MILLION
* QTRLY NET LOSS PER SHARE (BASIC AND DILUTED) $0.56
* REVENUE WAS $8.6 MILLION FOR THREE MONTHS ENDED JUNE 30,
2022,
COMPARED TO $7.2 MILLION FOR THREE MONTHS ENDED JUNE 30, 2021
Source text for Eikon: ID:nPn79q7F7a
Further company coverage: CASI.O
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary